Glipizide XL (glipizide) extended release tablets, 5 mg , 500 count bottles, Rx only, Distributed by: Greenstone Ltd., Peapack, NJ --- NDC 59762-5032-2

FDA recall notice · announced February 12, 2014 · Greenstone

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

Glipizide XL (glipizide) extended release tablets, 5 mg , 500 count bottles, Rx only, Distributed by: Greenstone Ltd., Peapack, NJ --- NDC 59762-5032-2

Reason for recall

Failed Dissolution Specification; the bulk lot yielded an out of specification result at the 8 hr timepoint, 18 month interval

Notes

Distribution: US Nationwide (including PR)
Lot/code information: lot V112000, EXP Jun 2016
Quantity: 22,529 bottles
Status: Terminated
Products in this recall event:
- Glipizide XL (glipizide) extended release tablets, 5 mg , 500 count bottles, Rx only, Distributed by: Greenstone Ltd., Peapack, NJ --- NDC 59762-5032-2 (D-1059-2014)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.